doi: 10.1016/s0140-6736(81)91554-3.
Successful tumour immunotherapy with cimetidine in mice
- PMID: 6110864
- DOI: 10.1016/s0140-6736(81)91554-3
Item in Clipboard
Successful tumour immunotherapy with cimetidine in mice
Lancet.
.
Abstract
Cimetidine significantly slowed metastatic development and prolonged survival in tumour-bearing mice, in association with inactivation of suppressor cells. Pharmacological blockade of the suppressor cell system may represent a new strategy for successful immunotherapy of human neoplasia.
Similar articles
-
Cimetidine reduction of tumour formation in mice.Lancet. 1981 Mar 21;1(8221):638-40. doi: 10.1016/s0140-6736(81)91555-5. Lancet. 1981. PMID: 6110865
-
Cimetidine protection against lethal tumor challenge in mice.Surgery. 1981 Aug;90(2):344-51. Surgery. 1981. PMID: 6454981
-
Cimetidine, the immune system, and cancer.Lancet. 1981 Apr 18;1(8225):900-1. Lancet. 1981. PMID: 6112323 No abstract available.
-
Cimetidine: an immunomodulator.DICP. 1990 Mar;24(3):289-95. doi: 10.1177/106002809002400316. DICP. 1990. PMID: 2138376 Review.
-
Cimetidine 6 years later: a review.Can J Surg. 1983 Jul;26(4):312-5. Can J Surg. 1983. PMID: 6134575 Review.
Cited by
-
Synergistic antitumor activity of interleukin-2 and cimetidine against syngeneic murine tumor.Cancer Immunol Immunother. 1991;33(1):9-14. doi: 10.1007/BF01742521. Cancer Immunol Immunother. 1991. PMID: 2021961 Free PMC article.
-
Histamine receptor antagonism and anti-tumour activity.Br J Cancer. 1982 Nov;46(5):817-20. doi: 10.1038/bjc.1982.276. Br J Cancer. 1982. PMID: 6128996 Free PMC article. No abstract available.
-
Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis.Clin Exp Metastasis. 1993 May;11(3):275-83. doi: 10.1007/BF00121170. Clin Exp Metastasis. 1993. PMID: 8097142
-
Role of histamine in the antitumour activity of endotoxin.Cancer Immunol Immunother. 1984;17(1):33-7. doi: 10.1007/BF00205494. Cancer Immunol Immunother. 1984. PMID: 6563942 Free PMC article.
-
Clinically feasible approaches to potentiating cancer cell-based immunotherapies.Hum Vaccin Immunother. 2015;11(4):851-69. doi: 10.1080/21645515.2015.1009814. Hum Vaccin Immunother. 2015. PMID: 25933181 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
